Core Focus
Our Scientific Directions
Organic Small Molecular Theranostic Drugs
Develop optical/radioactive small molecular probes for disease earlier detection and treatment. Our group focus on NIR-II fluorescent (1000-1700 nm) and PET imaging theranostic probe development.
Multi-target/Complex Pharmacology
The organism is a complex system. Using proteins and cells to screen drugs is increasingly unsatisfactory. Our group develops cheap in vivo imaging methods for multi-target/complex pharmacology drug development.
New NIR-II/SWIR Imaging Systems
Our group develops new NIR-II fluorescent imaging systems for cheap, fast, high throughput in vivo imaging. Those setups can be used for theranostic drug development and pharmacodynamics evaluation.
Research Paradigm
Imaging setup
Imaging processing algorithm
Probe
Leading compounds
Target/mechanism identification
Pharmacodynamic evaluations